Gnosis by Lesaffre launches vitaMK7 Matrix for more complex formulations

Photo © Shutterstock.com/photographyfirm

Gnosis by Lesaffre (Marcq-en-Baroeul, France) has introduced a new version of its vitaMK7 natural vitamin K2 with enhanced protection, called vitaMK7 Matrix. The innovation is the result of a proprietary technology that protects particles of MK-7 with no coating, no additives, and no additional ingredients.

“Stability is a constant issue facing commercial partners with the desire to create complex vitamin K2 formulations. Historically our R&D Team has been able to guide them through the process to ensure their products were stable,” said Sophie Legrain-Raspaud, PhD, global research and applications director with Gnosis by Lesaffre, in a press release. “With vitaMK7 Matrix, that process is now more efficient because the matrix carrier embeds the K2 as MK7 particles in the product, thus leading to products hitting the market much faster.”

Research has shown that the need for protective technology that shelters menaquinone molecules during shelf life can be traced to moisture and mineral salts as critical variables for degradation. VitaMK7 Matrix addresses these issues while providing a less cumbersome and more predictable formulation process for complex K2 products. Its benefits include improved homogeneity of the powder, high stability, especially with mineral complexes, and the ability for formulas to keep a short and unchanged list of ingredients without additives.

“This is an important improvement we are excited to share with our commercial partners and the global market,” added Xavier Berger, global market manager at Gnosis by Lesaffre. “Enhancing protection of the MK-7 molecule is an important element for those seeking to explore complex formulations that will truly impact health. Our team has worked extensively to ensure that our innovation was truly unique to the market, and most importantly, that it would have a tremendous impact on those with a vision for what the market needs.”